The global orthobiologics market is estimated to be valued at USD 7.21 Bn in 2024 and is expected to exhibit a CAGR of 6.2% during the forecast period (2024-2031). Orthobiologics are biological substitutes used in orthopedic applications to aid the healing of damaged musculoskeletal tissues such as ligaments, tendons, bone, and cartilage. They provide the building blocks for tissue repair and regeneration and help enhance the body's natural healing processes. Increasing incidences of orthopedic diseases and sports injuries, rapidly growing geriatric population, and technological advancements in the field of tissue engineering and regenerative medicine are some of the key factors driving the orthobiologics market. However, high costs associated with orthobiologics procedures and stringent regulatory frameworks are limiting the market growth.
Market Dynamics:
The global orthobiologics market is driven by the rising prevalence of osteoarthritis and other degenerative musculoskeletal conditions attributed to sedentary lifestyles and growing geriatric population. Moreover, increasing participation in sports and recreational activities has led to a surge in orthopedic injuries propelling the demand for advanced treatment options such as orthobiologics. However, high costs associated with orthobiologics procedures restrict the market growth to some extent. On the other hand, ongoing research & development activities for new product approvals and launches present lucrative opportunities for market players. For instance, innovations in stem cell-based therapies offer promising alternatives for tissue regeneration in orthopedic applications.
Key Features of the Study:
- This report provides an in-depth analysis of the global orthobiologics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global orthobiologics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study Zimmer Biomet, Bone Biologics Corp., Globus Medical, Stryker, ATEC Spine, Inc., XTANT MEDICAL, Johnson & Johnson Services, Inc., Exactech, Inc., NuVasive, Inc., Orthofix US LLC., SeaSpine, Spine Wave, Inc., Locate Bio Limited, Cerapedics, Ossifix Orthopedics, Arthrex Inc., and MTF Biologics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global orthobiologics market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global orthobiologics market
Detailed Segmentation-
- By Product Type:
-
- Bone Allograft
- Machined Bones
- Demineralized Bone Matrix
- Synthetic Bone Substitutes
- Bone Morphogenetic Protein (BMP)
- Others
- By Application:
-
- Spinal Fusion
- Trauma Fixation
- Reconstructive Joint Surgery
- Others
- By End User:
-
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers
- Others
- By Region:
-
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
-
- Zimmer Biomet
- Bone Biologics Corp.
- Globus Medical
- Stryker
- ATEC Spine, Inc.
- XTANT MEDICAL
- Johnson & Johnson Services, Inc.
- Exactech, Inc.
- NuVasive, Inc.
- Orthofix US LLC.
- SeaSpine
- Spine Wave, Inc.
- Locate Bio Limited
- Cerapedics
- Ossifix Orthopedics
- Arthrex Inc.
- MTF Biologics